EZH2 catalyzes H3K27me3, repressing pro-inflammatory and anti-tumor genes in TANs; therefore, EZH2 inhibition can restore neutrophil-mediated tumor cytotoxicity [133]. Here, EZH2 is linked to neoplasm.